Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, Steady_T, Grim Reaper, grich1, Battle Ready, Lima4918
Search This Board: 
Last Post: 10/21/2019 11:38:05 PM - Followers: 754 - Board type: Free - Posts Today: 129

Anavex Life Sciences Corp (AVXL)

Company website:  http://www.anavex.com/
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052

Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer.  The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.

Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease.  ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors.  Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others.  The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial.  ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.

The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.

Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL

Management:   http://www.anavex.com/about-us/leadership/
Pipeline:  http://www.anavex.com/pipeline/

Patent Info: 

Clinical Trials:  https://clinicaltrials.gov/ct2/results?term=Anavex+Life+Sciences&Search=Search
Recent News:  http://finance.yahoo.com/q?s=avxl&ql=1
Company News Releases:  http://www.anavex.com/2015/?post_type=news
Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=anavex&owner=exclude&action=getcompany
Share Structure:  See SEC filings
Investor Relations:  ir@anavex.com

Marketing Details:  http://convention.bio.org/Printables/Anavex%20Life%20Sciences%20Corp..html


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL News: Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease 10/09/2019 07:00:00 AM
AVXL News: Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’... 10/02/2019 07:00:00 AM
AVXL News: Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from th... 09/27/2019 03:00:00 AM
AVXL News: Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference 09/26/2019 07:00:00 AM
AVXL News: Notice of Effectiveness (effect) 09/23/2019 06:35:19 AM
#215561  Sticky Note AVXL Miracle Drug With A Toxic Financing Grim Reaper 10/21/19 06:06:19 PM
#212098  Sticky Note Compiled Due Diligence 09/29/19 XenaLives 09/29/19 12:04:35 PM
#203589  Sticky Note RE: ERP / COGNISION - I am surprised seventhwave 07/27/19 05:58:54 PM
#197446  Sticky Note EVERYONE get back and stay on-topic. The topic IH Geek [Dave] 06/20/19 03:19:35 PM
#215593   Right. Well, somebody has been screwing us so bb8675309 10/21/19 11:38:05 PM
#215592   Fred was purchasing Medivation as a penny stock Jager997 10/21/19 10:50:54 PM
#215591   LOL! for all you know it was the XenaLives 10/21/19 10:42:18 PM
#215590   It would be nice to see Baker Brothers bb8675309 10/21/19 10:24:26 PM
#215585   An applicable film for all to watch is powerwalker 10/21/19 09:55:37 PM
#215584   Longs will hold no matter. Company might basparks79 10/21/19 09:36:25 PM
#215583   This is not a slam dunk. basparks79 10/21/19 09:32:55 PM
#215582   I would be really disappointed if that were SquealingSquid 10/21/19 09:30:19 PM
#215581   Some here contend that the trials are already basparks79 10/21/19 09:29:21 PM
#215578   It’s 38 people. Not enough to draw definitive Burg32 10/21/19 08:35:46 PM
#215577   Well $2.87 seems to agree. As they say the Amatuer17 10/21/19 08:34:54 PM
#215576   I have NEVER seen scientific data equivalent to XenaLives 10/21/19 08:30:54 PM
#215574   Nearly all biotech stock investors get impressed with Amatuer17 10/21/19 08:28:53 PM
#215572   Yet that "toxic" financing has advanced the science, XenaLives 10/21/19 08:05:57 PM
#215571   Not applicable - a whole group of investors XenaLives 10/21/19 07:54:43 PM
#215569   "Shouldn’t we be hearing about full enrollment"--long overdue--what's plexrec 10/21/19 07:06:40 PM
#215568   Thanks for that clarification Ray. You are always NCMadman 10/21/19 07:05:15 PM
#215567   Rett and PDD trials were FULLY ENROLLED MONTHS AGO. rayovacAAA 10/21/19 06:46:02 PM
#215566   Very nice - very much applicable to AVXL Amatuer17 10/21/19 06:42:03 PM
#215564   Not very interesting - 2016.. XenaLives 10/21/19 06:14:30 PM
#215563   Shouldn’t we be hearing about full enrollment of SquealingSquid 10/21/19 06:13:07 PM
#215561  Restored AVXL Miracle Drug With A Toxic Financing Grim Reaper 10/21/19 06:06:19 PM
#215559   JW, thanks for posting. rocalinda 10/21/19 06:00:26 PM
#215548   MISSLING PROMISED RESULTS IN 2017!!!!!!! rayovacAAA 10/21/19 04:09:41 PM
#215547   Float is getting pretty tight. Not going to Bourbon_on_my_cornflakes 10/21/19 04:07:27 PM
#215540   SHORTS GONNA BURN WHEN TGD RELEASES THE TRIFECTA!!!!!!!! rayovacAAA 10/21/19 03:43:04 PM
#215537   Float is getting pretty tight. Not going to mrplmer 10/21/19 03:24:02 PM
#215535  Restored Biotech: When Good Drugs Go Bad By Ben Levisohn Grim Reaper 10/21/19 03:19:12 PM
#215532   SOME GUY NAMED FRED OWNS AVXL SHARES!!!!!!! rayovacAAA 10/21/19 02:32:40 PM
#215531   I doubt it matches with the Biochecking remit. Investor2014 10/21/19 02:32:30 PM
#215530   Bio checker needs to Biocheck Fred Knoll and JWC3 10/21/19 02:30:49 PM
#215529   EXPECT RETT, PDD, and ALZ TRIAL RESULTS AND rayovacAAA 10/21/19 02:25:49 PM
#215528   It is possible, but why do I get Investor2014 10/21/19 02:07:31 PM
#215527   Don’t you think Fred will make BM more JWC3 10/21/19 02:06:25 PM
#215526   I know, I made a neat sum from Investor2014 10/21/19 02:02:14 PM
#215525   Read This: https://www.forbes.com/sites/nathanvardi/2016/05/12/the-man-who-made JWC3 10/21/19 02:01:15 PM
#215524   Please read the Forbes article on Fred Knoll. JWC3 10/21/19 01:58:18 PM
#215523   Claiming on a message board to have acquaintances Investor2014 10/21/19 01:53:40 PM
#215522   Or rather, Fred Knoll is a serious investor JWC3 10/21/19 01:53:18 PM
#215521   Serious biotech investors who actually know science and Bourbon_on_my_cornflakes 10/21/19 01:50:05 PM
#215520   I suppose Fred Knoll is not a serious investor? JWC3 10/21/19 01:50:02 PM
#215519   Serious biotech investors who actually know science and BIOChecker4 10/21/19 01:46:47 PM
#215518   And this is achieved through posting a load Investor2014 10/21/19 01:09:41 PM
#215517   You forget to say, "and don't sell based Gernee20 10/21/19 01:08:46 PM
#215515   Keeping it real means recognizing the extreme risk BIOChecker4 10/21/19 01:04:36 PM
#215514   In the absence of answers it seems I Investor2014 10/21/19 12:45:27 PM
#215513   Help me to understand what action I as Investor2014 10/21/19 12:04:13 PM
#215512   When I'm not busy being mad at you baltimorebullet 10/21/19 11:50:24 AM
#215511   Happy to help you keep it real! BIOChecker4 10/21/19 11:48:05 AM